About Avivia
Avivia is an independent Pharmaceutical Development Organization CD(M)O located in the Netherlands (EU), and your partner in drug formulation, reformulation, repurposing, repositioning and generation or protection of intellectual property.
Avivia is specialized in medicinal product development. From product evaluation to comprehensive formulation and analytical development, excipient characterisation, reverse engineering, dissolutiontest development,stability studies, IMPD production, CMO selection and transfer.
Our expertise and capabilities are centred around formulation and CMC development of both generic drugs, life cycle management of branded drug products and new drug products (NCE).
History
Established in 2005, the company has built a solid reputation recognized for its R&D flexibility and ‘out-of-the-box’ approach towards complex and challenging analytical and pharmaceutical development projects. Today, we are the preferred partner for many big pharma, specialty pharma, generic drug companies, academic centra, and smaller drug development firms. Our offices and state-of-the-art laboratories are located in Nijmegen, The Netherlands, in close proximity to the German and Belgian borders.
Avivia leadership team
Lee Ayres – Managing Director
Lee Ayres is responsible for overall management of the company, strategy, marketing and business development. Before joining Avivia, Lee was CTO and co-founder of Encapson, a company specializing in coating for medical devices, where he led development of the Sono-Coat technology. Alongside being a member of the Management Team, as CTO he led the business development, sales, marketing and technical development activities. The Sono-Coat technology was acquired by LipoCoat in 2024. Lee holds a Master’s Degree in Chemistry from University of York and a PhD from the Radboud University of Nijmegen in Bio-Organic Chemistry.
Menno Wiltink – Sientific Director
Mr. Wiltink is a Partner in Avivia who has 25 years of experience in the pharmaceutical R&D with expertise in analytical research and support, API, Excipient and drug product characterization and troubleshooting, predictive dissolution testing, preclinical evaluation and equivalence selection. He was heading the Analytical R&D Department at Synthon BV and studied Analytical Sciences at the University in Amsterdam and Environmental Analysis at the Van Hall Larenstein, University of Applied Sciences. He joined Avivia as a partner in 2014 and set up analytical R&D CRO lab services, as well as a platform for a dissolution support and method development, and Excipia for excipient characterization and reverse engineering of medicines.
Dennie van den Heuvel – Development Director
Mr. van den Heuvel is a Partner in Avivia who has over 20 years working experience in the pharmaceutical industry and is an expert in formulation development. Related topics range from preclinical development up to the market formulation including production, IP and regulatory requirements. He held different positions at Intervet/Akzo-Nobel and Synthon and has extensive experience in project management, working in and leading/coaching interdisciplinary teams (CMC, Toxicology, Clinical, Regulatory, Analytics). He is an inventor of 25+ patents in name of Synthon. He joined Avivia as a partner in 2014 and set up pharmaceutical R&D CRO lab services and Siloxia for silica based technologies.
Careers
Avivia is growing so we are constantly looking for Junior and Senior Scientists (Pharmaceutical Development) to join our team and to help us achieve our goals. We are keen on people who say what they’ll do and do it, are 100% focused on results and success, have a strong personality (but not too strong), and want to work in pharma for the right reasons. If you are interested to join our team, don’t hesitate to let us know. Get in touch.
